83
14
3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10505 | PPARα-MO-1 | PPAR | |
PPARα-MO-1 is a potent modulator of PPARα. | |||
T62968 | PPARα/δ agonist 1 | ||
PPARα/δ agonist 1 is a potent PPARα/PPARδ dual agonist with EC50 values of 7.0 nM for PPARα and 8.4 nM for PPARδ. PPARα/δ agonist 1 exhibits high selectivity for PPARγ (EC50: 1316.1 nM). agonist 1 has potential for non-a... | |||
T62266 | PPARα agonist 1 | ||
PPARα agonist 1 is a complete and potent PPARα agonist. | |||
T60535 | PPARα/γ agonist 1 | ||
PPARα/γ agonist 1 is a potent and dual PPARα/γ partial agonist which is a promising prototype for the research of dyslipidemia and diabetes. PPARα/γ agonist 1 has EC50 values of 28 nM and 69 nM for PPARα and PPARγ, respe... | |||
T14933 | Cetaben | Others | |
Cetaben is a PPARα-independent peroxisome proliferator and is a non-fibrate hypolipidemic drug. It potent reduces the concentration of cholesterol and triglycerides. | |||
T10900 | CUDA | PPAR , Epoxide Hydrolase | |
CUDA is an effective soluble cyclohydrolase inhibitor with IC50 of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively. CUDA selectively increases the activity of peroxisome proliferator-activated receptor (PPAR... | |||
T15821 | LY518674 | LY-674 | PPAR |
LY518674 (LY-674) decreases triglycerides and increases HDL-C and is used for the treatment of atherosclerosis. LY518674 is an effective and selective PPARα agonist (EC50: 42 nM for human PPARα). | |||
T4328 | OSS_128167 | SIRT6-IN-1 | HBV , Sirtuin |
OSS_128167 (SIRT6-IN-1) is a specific SIRT6 inhibitor, and for SIRT6(IC50=89 μM), SIRT1(IC50=1578 μM) and SIRT2(IC50=751 μM). | |||
T6893 | MK-886 | MK886,L 663536 | Apoptosis , Leukotriene Receptor , COX , PPAR , FLAP |
MK-886 (L 663536) is an inhibitor of leukotriene biosynthesis, inhibiting 5-lipoxygenase-activating protein (FLAP). It is also a moderately potent PPARα antagonist. | |||
T15453 | GW7647 | PPAR | |
GW7647 is a potent agonist of PPARα (EC50s: 6 nM, 1.1 μM, and 6.2 μM for human PPARα, PPARγ, and PPARδ, respectively). | |||
T8374 | LJ570 | PPAR | |
LJ570 is the first PPARα/γ dual agonist (PPARα,PPARγ with EC50s of 1.05 and 0.12 μM, respectively[) | |||
T17044 | Tesaglitazar | PPAR | |
Tesaglitazar is a potent and selective peroxide PPARα / γ receptor dual agonist with a more potent affinity for PPARγ than PPARα, The EC50 values for rat PPARα and human PPARα were 13.4 μM and 3.6 μM, respectively, and 0... | |||
T8699 | GFT505 | Elafibranor | PPAR |
GFT505 (Elafibranor) (Elafibranor) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively. | |||
TQ0107 | Pemafibrate | (R)-K-13675 | PPAR |
Pemafibrate ((R)-K-13675) is a highly specific PPARα agonist (EC50: 1 nM). | |||
TQ0120 | CDDO-Im | RTA-403,CDDO-Imidazolide,TP-235 | Others , Ferroptosis , Nrf2 , PPAR |
CDDO-Im (TP-235) is an activator of Nrf2 and PPAR (Kis: 232/344 nM for PPARα/PPARγ). | |||
T14176 | Aleglitazar | RO0728804,R1439 | PPAR |
Aleglitazar (R1439) (R1439) is a potent dual PPARα/γ agonist, with IC50s of 38 nM and 19 nM for human PPARa and PPARγ, respectively. Aleglitazar can be used for the research of type II diabetes. | |||
T12835 | Saroglitazar | Lipaglyn | PPAR |
Saroglitazar (Lipaglyn) is an agonist of PPAR with EC50 values of 0.65 pM and 3 nM for PPARα and PPARγ. | |||
T12834 | Saroglitazar Magnesium | Others | |
Saroglitazar Magnesium is a novel peroxissome proliferator-activated receptor (PPAR) agonist with significant activation activity against PPARα (EC50 0.65pM) and moderate activation against PPARγ (EC50 3 nM). | |||
T7395 | Lanifibranor | IVA337 | PPAR |
Lanifibranor (IVA337) is an agonist of peroxisome proliferator-activated receptors (PPARs) with EC50 values of 1,537, 866, and 206 nM for human recombinant PPARα, PPARβ, and PPARγ, respectively, for transactivation activ... | |||
T9766 | GW590735 | PPAR | |
GW590735 is an effective and selective PPARα agonist with an EC50 of 4 nM on PPARα and at least 500-fold selectivity versus PPARδ and PPARγ. GW590735 can be used in dyslipidemia studies. | |||
T5532 | BMS-687453 | PPAR | |
BMS-687453 is a potent and selective PPAR alpha agonist, with an EC(50) of 10 nM for human PPARalpha and approximately 410-fold selectivity vs human PPARgamma in PPAR-GAL4 transactivation assays. | |||
T21764 | MCC-555 | Isaglitazone,Netoglitazone | PPAR |
MCC-555 (Isaglitazone) is a PPARα and PPARγ agonist exerting antihyperglycemic effects. | |||
T2269 | Pirinixic Acid | Wy-14643,NSC 310038 | PPAR |
Pirinixic Acid (NSC 310038) is a synthetic thiacetic acid derivative used in biomedical research, carcinogenic Pirinixic acid is a peroxisome proliferator that activates specific peroxisome proliferator-activated recepto... | |||
T6689 | T0070907 | PPAR | |
T0070907(IC50=1 nM) , an effective and specific PPARγ inhibitor, with the >800-fold selectivity over PPARα and PPARδ. | |||
T8486 | GW6471 | GW 6471 | PPAR |
GW6471 is an antagonist of PPARα with IC50 of 0.24 μ M. GW6471 enhances the binding affinity of the PPAR α ligand-binding domain to the co-repressor proteins SMRT and NCoR. | |||
T28501 | Ragaglitazar | NNC61-0029,NN-622,(-)-DRF-2725,NNC-61-0029,NN 622,NNC 61-0029 | PPAR |
Ragaglitazar(NNC-61-0029) is a potent dual PPARα and PPARγ agonist that has shown potent lipid-lowering and insulin sensitizing effects in animal models.Ragaglitazar can be used to study type 2 diabetes. | |||
T21587 | Muraglitazar | Pargluva,BMS-298585 | PPAR |
Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARα and PPARγ with EC50 of 320 nM and 110 nM r... | |||
T2260 | GW9662 | TIMTEC-BB SBB006523,GW 9662 | PPAR |
GW9662 (TIMTEC-BB SBB006523) is a specific PPARγ antagonist (IC50: 3.3 nM, in a cell-free assay), with 100 to 1000-fold functional selectivity for PPARγ than PPARα/δ in cells. | |||
T6524 | GW0742 | GW610742 | PPAR |
GW0742 (GW610742) is an effective and specific PPARδ agonist (EC50: 1 nM/1.1 μM/2 μM, for human PPARδ/α/γ). | |||
T1298 | Clofibrate | Clofibrato,Clofibratum,Ethyl clofibrate | PPAR |
Clofibrate (Clofibrato) is an aryloxyisobutyric acid derivate with antihyperlipidemic activity. | |||
T63898 | Benzo[b]thiophene-7-propanoic acid, α-methoxy-4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-, (αR)- | PPAR | |
Benzo[b]thiophene-7-propanoic acid, α-methoxy-4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-, (αR)- is a dual PPARα/γ agonist with EC50 of 0.358μM and 1.21μM. Benzo[b]thiophene-7-propanoic acid, α-methoxy-4-[2-(5-methyl-2-p... | |||
T9808 | Tetradecylthioacetic acid | PPAR | |
Tetradecylthioacetic acid is a synthetic fatty acid with a sulfur substitution in the β-position. This modification renders TTA unable to undergo complete β-oxidation and increases its biological activity, including acti... | |||
T0841 | Bezafibrate | BM15075 | PPAR |
Bezafibrate (BM15075) is an antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW-DENSITY LIPOPROTEINS and increases HIGH-DENSITY LIPOPROTEINS. | |||
T1149 | Fenofibrate | Procetofen,Lipanthyl,Lipantil | P450 , PPAR , Autophagy |
Fenofibrate (Lipanthyl) is a peroxisome proliferator receptor alpha agonist. Fenofibrate is a synthetic phenoxy-isobutyric acid derivate and prodrug with antihyperlipidemic activity. | |||
T1402 | Fenofibric acid | Trilipix,FNF acid,NSC 281318 | MMP , COX , PPAR |
Fenofibric acid (FNF acid) is the active form of fenofibrate, a synthetic phenoxy-isobutyric acid derivate with antihyperlipidemic activity. | |||
T7796 | TUG-1375 | GPR | |
TUG-1375 is an Agonist of Thiazolidine Free Fatty Acid Receptor 2 | |||
T1264 | Ciprofibrate | Win35833 | PPAR |
Ciprofibrate (Win35833) is a fibrate derivative with antilipidemic activity. | |||
T0061 | Clofibric acid | Chlorofibrinic acid | PPAR , Drug Metabolite |
Clofibric acid (Chlorofibrinic acid) is an antilipemic agent that is the biologically active metabolite of CLOFIBRATE. | |||
T14356 | AVE-8134 | PPAR | |
AVE-8134 is an agonist of PPARα. For human and rodent PPARα receptor, the EC50 values are 100 and 3000 nM, respectively. | |||
T14948 | Chiglitazar | PPAR | |
Chiglitazar is a dual agonist of PPARα/γ (EC50s: 1.2, 0.08, and 1.7 μM for PPARα, PPARγ, and PPARδ). | |||
T4628 | Seladelpar | MBX 8025 | PPAR |
Seladelpar (MBX 8025) has been used in trials studying the treatment of Hyperlipidemia. | |||
T15243 | Ertiprotafib | PTP 112 | Phosphatase , PPAR |
Ertiprotafib is a PTP1B, IkB kinase β (IKK-β), and a dual PPARα and PPARβ agonist inhibitor ( IC50s: 1.6 μM for PTP1B, 400 nM for IKK-β, an EC50 of ~1 μM for PPARα/PPARβ). | |||
T27519 | GW 9578 | GW9578,GW-9578 | PPAR |
GW 9578 is a selective and potent PPARα agonist with potent lipid-lowering activity for the study of psoriasis, arthritis, alopecia, asthma and type I diabetes. | |||
T12278 | NXT629 | Estrogen/progestogen Receptor | |
NXT629 is a selective and competitive antagonist of PPAR-α(human PPARα with an IC50 of 77 nM). | |||
T22686 | CP 775146 | Others | |
PPARα agonist | |||
T4408 | Elafibranor | GFT505 | PPAR |
Elafibranor (GFT505) is an agonist of the peroxisome proliferator-activated receptor-α (PPAR-α) and peroxisome proliferator-activated receptor-δ (PPAR-δ) with EC50 values of 45 and 175 nM, respectively. | |||
T37833 | CAY10767 | ||
CAY10767 is an agonist of peroxisome proliferator-activated receptor α (PPARα; EC50= 37 nM in a reporter assay).1It is greater than 2,700-fold selective for PPARα over PPARγ or PPARδ. | |||
T30539 | BMS-711939 | BMS 711939,BMS711939 | |
BMS-711939 is a potent and specific peroxisome proliferator-activated receptor (PPARα) agonist that has demonstrated excellent efficacy and safety in vivo in preclinical studies with an EC50 of 4 nM for PPARα in humans. | |||
T68974 | MHY553 | ||
MHY 553 is a PPARα agonist that improved aged-induced hepatic steatosis. | |||
T31083 | CP-868388 free base | CP868388,CP 868388,(-)-CP-868388,UNII-999KY5ZIGB,CP-868388 | PPAR |
CP-868388 free base (CP-868388) is an orally active, potent and selective PPARα agonist with hypolipidemic and anti-inflammatory activity for the study of dyslipidemia. |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7052 | Gnetol | Tyrosinase , COX , HDAC , AChR | |
Gnetol competitivity inhibits butyrylcholinesterase (IC50: 1.3 uM). Gnetol has a strong inhibitory effect on murine tyrosinase activity. Gnetol significantly suppresses melanin biosynthesis in murine B16 melanoma cells. ... | |||
T2855 | Icariin | Ieariline | PDE , PPAR , Autophagy |
Icariin (Ieariline) is a flavonol glycoside, inhibiting PDE5 and PDE4 activities. Icariin also is a PPARα activator. | |||
T3362 | Eupatilin | NSC 122413 | PPAR , Autophagy |
Eupatilin (NSC-122413), a flavone derived from Artemisia princepsPampanini, is a PPARα agonist, with pharmacological activity. | |||
T8184 | Fucosterol | PARP , Endogenous Metabolite , PPAR | |
Fucosterol is isolated from E. stolonifera with anti-diabetic, anti-adipogenic and anti-cancer activities. It regulates adipogenesis via modulation of PPARα and C/EBPα expression. | |||
T4S2128 | Bilobetin | PKA , PPAR | |
Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARα in rats fed a high-fat diet. | |||
TN1990 | Norathyriol | Akt , DNA/RNA Synthesis , AMPK , PPAR | |
Norathyriol is a potent PTP1B inhibitor with good cell permeability and oral availability. | |||
T3S1701 | Dihydrocurcumin | PPAR , Fatty Acid Synthase | |
Dihydrocurcumin is the main metabolite of curcumin, which can reduce fat accumulation and oxidative stress response. Dihydrocurcumin can regulate the mRNA and protein expression levels of SREBP-1C, PNPLA3 and PPARα, incr... | |||
T3254 | PHYTOL | trans-Phytol,(E)-Phytol | Antibacterial , PPAR , Parasite |
PHYTOL (trans-Phytol) , a diterpene alcohol from chlorophyll widely used as a food additive and in medicinal fields, shows antinociceptive and antioxidant activities as well as anti-inflammatory and antiallergic effects.... | |||
T6926 | Palmitoylethanolamide | Mackpeart DR 14V,N-palmitoylethanolamine,Loramine P 256,Impulsin,AM 3112,Palmidrol | Influenza Virus , Endogenous Metabolite , PPAR |
Palmitoylethanolamide (Impulsin) is an endogenously fatty acid amide. It has a role as an anti-inflammatory drug, an antihypertensive agent, a neuroprotective agent and an anticonvulsant.Upon administration, palmitoyleth... | |||
T75690 | Wistin | ||
Wistin, isolated from Caragana sinica roots, is a PPARα and PPARγ agonist [1] [2] . | |||
T10044 | 13-Oxo-9E,11E-octadecadienoic acid | PPAR | |
13-Oxo-9E,11E-octadecadienoic acid, a potent PPARα activator derived from tomato juice and an isomer of 9-oxo-ODA, exhibits the ability to decrease plasma and hepatic triglyceride levels in obese diabetic mice[1]. | |||
TN5149 | Tirotundin | NF-κB , COX , PPAR | |
Tirotundin is a PPARα/γ dual agonist, it exerts anti-diabetic effect through PPARγ pathway. It shows anti-inflammatory activity, it inhibits inhibit the activation of NF-kappa B, thereby, the synthesis of inflammatory me... | |||
T3056 | Bavachinin | Bavachinin A,7-O-Methylbavachin | PPAR |
Bavachinin (Bavachinin A)(7-O-Methylbavachin) is a natural compound isolated from the Chinese herb Fructus Psoraleae with potent anti-angiogenic activity. | |||
TN5091 | Tagitinin A | PPAR , Antifection | |
Tagitinin A is a plant insecticidal compound, it has phytotoxic activity, it shows significant inhibition of wheat coleoptile growth, seed germination, and the growth of STS and weeds. Tagitinin A is also a PPARα/γ dual ... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-06830 | PPAR alpha/PPARA Protein, Human, Recombinant (His) | Human | E. coli |
Peroxisome proliferators include hypolipidemic drugs, herbicides, leukotriene antagonists, and plasticizers; this term arises because they induce an increase in the size and number of peroxisomes. Peroxisomes are subcell... | |||
TMPY-06837 | PPAR alpha/PPARA Protein, Mouse, Recombinant (His) | Mouse | E. coli |
Peroxisome proliferators include hypolipidemic drugs, herbicides, leukotriene antagonists, and plasticizers; this term arises because they induce an increase in the size and number of peroxisomes. Peroxisomes are subcell... | |||
TMPY-03499 | CARHSP1 Protein, Human, Recombinant (His) | Human | E. coli |
CARHSP1 is a biomarker for diabetic complications. Adenovirus-mediated CARHSP1 overexpression and siRNA-mediated knockdown experiments were performed to characterize the role of CARHSP1 in the regulation of gluconeogen... |